The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer

Peter Barry(Royal Marsden Hospital), Alexandra Vatsiou(Evolutionary Genomics (United States)), Inmaculada Spiteri(Evolutionary Genomics (United States)), Daniel Nichol(Evolutionary Genomics (United States)), George D. Cresswell(Evolutionary Genomics (United States)), Ahmet Acar(Evolutionary Genomics (United States)), Nicholas Trahearn(Evolutionary Genomics (United States)), Sarah Hrebien(Breast Cancer Now), Isaac García-Murillas(Breast Cancer Now), Kate Chkhaidze(Evolutionary Genomics (United States)), Luca Ermini(Institute of Cancer Research), Ian Said Huntingford(Mater Dei Hospital), Hannah Cottom(Breast Cancer Now), Lila Zabaglo(Royal Marsden Hospital), Konrad Koelble(Royal Marsden Hospital), Saira Khalique(Royal Marsden Hospital), Jennifer Rusby(Royal Marsden Hospital), Francesca Muscarà(Royal Marsden Hospital), Mitch Dowsett(Royal Marsden Hospital), Carlo C. Maley(Evolutionary Genomics (United States)), Rachael Natrajan(Breast Cancer Now), Yinyin Yuan(Institute of Cancer Research), Gaia Schiavon(Breast Cancer Now), Nicholas C. Turner(Breast Cancer Now), Andrea Sottoriva(Evolutionary Genomics (United States))
Clinical Cancer Research
June 11, 2018
Cited by 50Open Access
Full Text

Abstract

Abstract Purpose: The most significant prognostic factor in early breast cancer is lymph node involvement. This stage between localized and systemic disease is key to understanding breast cancer progression; however, our knowledge of the evolution of lymph node malignant invasion remains limited, as most currently available data are derived from primary tumors. Experimental Design: In 11 patients with treatment-naïve node-positive early breast cancer without clinical evidence of distant metastasis, we investigated lymph node evolution using spatial multiregion sequencing (n = 78 samples) of primary and lymph node deposits and genomic profiling of matched longitudinal circulating tumor DNA (ctDNA). Results: Linear evolution from primary to lymph node was rare (1/11), whereas the majority of cases displayed either early divergence between primary and nodes (4/11) or no detectable divergence (6/11), where both primary and nodal cells belonged to a single recent expansion of a metastatic clone. Divergence of metastatic subclones was driven in part by APOBEC. Longitudinal ctDNA samples from 2 of 7 subjects with evaluable plasma taken perioperatively reflected the two major evolutionary patterns and demonstrate that private mutations can be detected even from early metastatic nodal deposits. Moreover, node removal resulted in disappearance of private lymph node mutations in ctDNA. Conclusions: This study sheds new light on a crucial evolutionary step in the natural history of breast cancer, demonstrating early establishment of axillary lymph node metastasis in a substantial proportion of patients. Clin Cancer Res; 24(19); 4763–70. ©2018 AACR.


Related Papers

No related papers found

Powered by citation graph analysis